Quick Answer
TransMedics Group, Inc. reported Stockholders Equity of $473.10 million for fiscal year 2025.
TransMedics Group, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $473.10M | +107.0% |
| 2024 | $228.60M | +66.6% |
| 2023 | $137.20M | -26.8% |
| 2022 | $187.38M | +176.1% |
| 2021 | $67.85M | -34.7% |
| 2020 | $103.89M | +90.1% |
| 2019 | $54.65M | +128.4% |
| 2018 | -$192.24M | -13.9% |
| 2017 | -$168.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $355.20M | +69.2% | +11.7% |
| June 30, 2025 | $318.10M | +67.5% | +19.4% |
| March 31, 2025 | $266.31M | +67.0% | +16.5% |
| December 31, 2024 | $228.60M | +66.6% | +8.9% |
| September 30, 2024 | $209.92M | +66.0% | +10.5% |
| June 30, 2024 | $189.89M | +30.8% | +19.1% |
| March 31, 2024 | $159.47M | -17.2% | +16.2% |
| December 31, 2023 | $137.20M | -26.8% | +8.5% |
- TransMedics Group, Inc. showed an increase of +107.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, TransMedics Group, Inc.’s stockholders equity has grown by 380.4% (from -$168.72 million to $473.10 million).
- The most recent figure is from TransMedics Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: